Inergetics Inc (fka NRTI)

[Dubb10]

FDA just issued a handful of warning letters to marketers of CBD products as dietary supplements. They aren't willing to classify CBD as both a new drug and a dietary supplement ingredient.

As it was speculated by some last year, this may be a key reason why Inergetics dropped Nulief.

Their inability to file financials on time may be a whole other matter.

Key paragraph:

FDA has concluded that CBD products are excluded from the dietary supplement definition under section 201(ff)(3)(B)(ii) of the Act [21 U.S.C. § 321(ff)(3)(B)(ii)]. Under that provision, if a substance (such as CBD) has been authorized for investigation as a new drug for which substantial clinical investigations have been instituted and for which the existence of such investigations has been made public, then products containing that substance are outside the definition of a dietary supplement. There is an exception if the substance was “marketed as” a dietary supplement or a conventional food before the new drug investigations were authorized; however, based on available evidence, FDA has concluded that this is not the case for CBD.
https://www.newcannabisventures.com/breaking-fda-cbd-warning-letters/